Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection.

Turnbull EL, Wong M, Wang S, Wei X, Jones NA, Conrod KE, Aldam D, Turner J, Pellegrino P, Keele BF, Williams I, Shaw GM, Borrow P.

J Immunol. 2009 Jun 1;182(11):7131-45. doi: 10.4049/jimmunol.0803658.


A nurse- and pharmacist-led treatment advice clinic for patients attending an HIV outpatient clinic.

Griffiths C, Miles K, Aldam D, Cornforth D, Minton J, Edwards S, Williams I.

J Adv Nurs. 2007 May;58(4):320-6. Epub 2007 Apr 17.


HIV-1 epitope-specific CD8+ T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently.

Turnbull EL, Lopes AR, Jones NA, Cornforth D, Newton P, Aldam D, Pellegrino P, Turner J, Williams I, Wilson CM, Goepfert PA, Maini MK, Borrow P.

J Immunol. 2006 May 15;176(10):6130-46.


Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia.

Bourboulia D, Aldam D, Lagos D, Allen E, Williams I, Cornforth D, Copas A, Boshoff C.

AIDS. 2004 Feb 20;18(3):485-93.


P-glycoprotein and MRP1 expression and reduced ritonavir and saquinavir accumulation in HIV-infected individuals.

Meaden ER, Hoggard PG, Newton P, Tjia JF, Aldam D, Cornforth D, Lloyd J, Williams I, Back DJ, Khoo SH.

J Antimicrob Chemother. 2002 Oct;50(4):583-8.


Safety, tolerance, and efficacy of atevirdine in asymptomatic human immunodeficiency virus-infected individuals.

Been-Tiktak AM, Williams I, Vrehen HM, Richens J, Aldam D, van Loon AM, Loveday C, Boucher CA, Ward P, Weller IV, Borleffs JC.

Antimicrob Agents Chemother. 1996 Nov;40(11):2664-8.


Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma.

Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, Hatzioannou T, Suggett FE, Aldam DM, Denton AS, et al.

Lancet. 1995 Sep 23;346(8978):799-802.


Supplemental Content

Support Center